Law firms

Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’

Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’

David Gibson, senior associate at McDermott Will & Emery

Why did you decide to specialise in life sciences law, and what’s the best thing about being a life sciences lawyer?

This article is for Legal Business subscribers. Please log in or subscribe to read on.